Brief: Trinity Biotech Announces Q1 2022 Financial Results
June 30 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES QUARTER 1 2022 FINANCIAL RESULTS
* Q1 REVENUE FELL 26.6 PERCENT TO $18.8 MILLION
* DILUTED LOSS PER ADS FOR Q1 2022 WAS 50.0 CENTS
Source text for Eikon: ID:nGNX4FR5c0
Further company coverage: TRIB.O
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM